Is It Too Late to Buy Novavax Stock?
Which stock has been the biggest winner among COVID-19 vaccine makers since early 2020? I'll give you a hint: It's not Pfizer (NYSE: PFE), BioNTech (NASDAQ: BNTX), or Moderna (NASDAQ: MRNA).
The correct answer to the question is Novavax (NASDAQ: NVAX). And it's not even a close contest. Novavax is by far the best-performing vaccine stock with a gain of more than 4,900% since the beginning of last year.
Few stocks achieve that kind of gain in such a short period of time. Of those that do, many of them quickly run out of steam. The risk could be even greater for shares of a company that hasn't even launched a product yet while rivals already dominate the market. Is it too late to buy Novavax stock?
Source Fool.com
